Aspirin use and cancers of the upper aerodigestive tract

British Journal of Cancer

Volumn 88, Issue 5, 2003, Pages 672-674

  Bosetti, C ^a   Talamini, R ^b   Franceschi, S ^c   Negri, E ^a   Garavello, W ^d   La Vecchia, C ^a,e  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^c INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^d SAN GERARDO HOSPITAL   (Italy)

^e UNIVERSITY OF MILAN   (Italy)

Author keywords

Aspirin; Case control study; Risk factor; Upper aerodigestive tract cancer

Indexed keywords

ACETYLSALICYLIC ACID;

ARTICLE; CANCER PREVENTION; CANCER RESEARCH; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG USE; FEMALE; GASTROINTESTINAL CARCINOMA; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; ESOPHAGEAL NEOPLASMS; HUMANS; MULTIVARIATE ANALYSIS; ODDS RATIO;

EID: 0037430063     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6600820     Document Type: Article

References (27)

1. Bosetti C, Gallus S, La Vecchia C (2002) Aspirin and cancer risk: an update to 2001. Eur J Cancer Prev 11: 535-542
2. Bosetti C, La Vecchia C, Talamini R, Simonato L, Zambon P, Negri E, Trichopoulos D, Lagiou P, Bardini R, Franceschi S (2000) Food groups and risk of squamous cell esophageal cancer in Northern Italy. Int J Cancer 87: 289-294
3. Breslow NE, Day NE (1980) Statistical Methods in Cancer Research. Vol. I, The Analysis of Case-Control Studies. IARC Sci Publs no. 32. Lyon: International Agency for Research on Cancer
4. Chan G, Boyle JO, Yang EK, Zhang F, Sacks PG, Shah JP, Edelstein D, Soslow RA, Koki AT, Woerner BM, Masferrer JL, Dannenberg AJ (1999) Cyclooxygenase-2 expression is up-regulated in squamous cell carcinoma of the head and neck. Cancer Res 59: 991-994
5. Farrow DC, Vaughan TL, Hansten PD, Stanford JL, Risch HA, Gammon MD, Chow W-H, Dubrow R, Ahsan H, Mayne ST, Schoenberg JB, West AB, Rotterdam H, Fraumeni Jr JF, Blot WJ (1998) Use of aspirin and other nonsteroidal anti-inflammatory drugs and risk of oesophageal and gastric cancer. Cancer Epidemiol Biomarkers Prev 7: 97-102
6. Featherstone C (1997) Aspirin for bowel cancer: an old friend finds a new role. Lancet 350: 418
7. Franceschi S, Levi F, Conti E, Talamini R, Negri E, Dal Maso L, Boyle P, Decarli A, La Vecchia C (1999) Energy intake and dietary pattern in cancer of the oral cavity and pharynx. Cancer Causes Control 10: 439-444
8. Funkhouser EM, Sharp GB (1995) Aspirin and reduced risk of oesophageal carcinoma. Cancer 76: 1116-1119
9. Garidou A, Tzonou A, Lipworth L, Signorello LB, Kalapothaki V, Trichopoulos D (1996) Life-style factors and medical conditions in relation to esophageal cancer by histologic type in a low-risk population. Int J Cancer 68: 295-299
10. Giovannucci E, Egan KM, Hunter DJ, Stampfer MJ, Colditz GA, Willett WC, Speizer FE (1995) Aspirin and the risk of colorectal cancer in women. N Engl J Med 333: 609-614
11. Gridley G, McLaughlin JK, Ekbom A, Klareskog L, Adami H-O, Hacker DG, Hoover R, Fraumeni Jr JF (1993) Incidence of cancer among patients with rheumatoid arthritis. J Natl Cancer Inst 85: 307-311
12. Hong WK, Sporn MB (1997) Recent advances in chemoprevention of cancer. Science 278: 1073-1077
13. IARC Handbooks of Cancer Prevention (1997) Non-Steroidal Anti-Inflammatory Drugs, Vol. 1. Lyon: International Agency for Research on Cancer
14. Isomäki HA, Hakulinen T, Joutsenlahti U (1978) Excess of lymphomas, leukemia, and myeloma in patients with rheumatoid arthritis. J Chron Dis 31: 691-696
15. Kelly JP, Rosenberg L, Kaufman DW, Shapiro S (1990) Reliability of personal interview data in a hospital-based case-control study. Am J Epidemiol 131: 79-90
16. Li M, Lotan R, Levin B, Tahara E, Lippman SM, Xu XC (2000) Aspirin induction of apoptosis in oesophageal cancer: a potential for chemoprevention. Cancer Epidemiol Biomarkers Prey 9: 545-549
17. Marcus AJ (1995) Aspirin as prophylaxis against colorectal cancer. N Engl J Med 333: 656-658
18. Marnett LJ (1992) Aspirin and the potential role of prostaglandins in colon cancer. Cancer Res 52: 5575-5589
19. Morgan G, Vainio H (1998) Barrett's oesophagus, oesophageal cancer and colon cancer: an explanation of the association and cancer chemopreventive potential of non-steroidal anti-inflammatory drugs. Eur J Cancer Prey 7: 195-199
20. Sharp L, Chilvers CED, Cheng KK, McKinney PA, Logan RFA, Cook-Mozaffari P, Ahmed A, Day NE (2001) Risk factors for squamous cell carcinoma of the oesophagus in women: a case-control study. Br J Cancer 85: 1667-1670
21. Smith ML, Hawcroft G, Hull MA (2000) The effect of non-steroidal anti-inflammatory drugs on human colorectal cancer cells: evidence of different mechanisms of action. Eur J Cancer 36: 664-674
22. Taketo MM (1998a) Cyclooxygenase-2 inhibitors in tumorigenesis (Part I). J Natl Cancer Inst 90: 1529-1536
23. Taketo MM (1998b) Cyclooxygenase-2 inhibitors in tumorigenesis (Part II). J Natl Cancer Inst 90: 1609-1620
24. Talamini R, Bosetti C, La Vecchia C, Dal Maso L, Levi F, Bidoli E, Negri E, Pasche C, Vaccarella S, Barzan L, Franceschi S (2002) Combined effect of tobacco and alcohol on laryngeal cancer risk: a case-control study. Cancer Causes Control 13: 951-964
25. Thun MJ, Henley SJ, Patrono C (2002) Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues. J Natl Cancer Inst 94: 252-266
26. Thun MJ, Namboodiri MM, Calle EE, Flanders WD, Heath Jr CW (1993) Aspirin use and risk of fatal cancer. Cancer Res 53: 1322 1327
27. Zimmermann KC, Sarbia M, Weber AA, Borchard F, Gabbert HE, Schror K (1999) Cyclooxygenase-2 expression in human esophageal carcinoma. Cancer Res 159: 198-204